Plus: A shift in bird flu strategy, a new vaccine for meningococcal disease, a new AI genomics model from Nvidia and more.

We recently published a list of the Top 10 AI Stocks Buzzing on Latest News. In this article, we are going to take a look at ...

Chris Gibson, Recursion’s head, cited the role small business grants played in helping Recursion grow its business.

Recursion CEO Chris Gibson defends the NIH, investing $1 million into a pre-seed venture to encourage critical research and ...

Recursion is advancing REC-617, a promising reversible, non-covalent CDK7 inhibitor, showing potential in treating advanced solid tumors with positive interim phase 1 data. Read more here.

That was the case for Recursion Pharmaceuticals ... Funding awards also come with admission to the Altitude accelerator program, which provides mentorship from industry executives and connections ...

Built on top of Erlang, Elixir makes it easier to write good functional programming code and harder to mess it up. Here's a ...

A Google software engineer's LinkedIn post admitting to a lack of fundamental coding skills—including SQL, Git, and even ...

Detailed price information for Recursion Pharmaceuticals Inc Cl A (RXRX-Q) from The Globe and Mail including charting and ...